By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – DVS Sciences today announced it has raised $14.6 million in a Series A financing round, which will be used to build up the company's manufacturing capabilities for its multiplexed single cell analysis technology.
Registering provides access to this and other free content.
Already have an account?Login Now.
The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.
The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.
The first Reproducibility Project: Cancer Biology papers show mixed results.
In Nature this week: mobile phone-based targeted DNA sequencing, and more.